Fluidigm Begins Early-Access Program for Automated Single-Cell Sample Prep System | GenomeWeb

Fluidigm said today that it has initiated an early-access program for its new C1 Single-Cell AutoPrep System for single-cell gene expression studies.

The new platform, the company claims, for the first time enables researchers to isolate cells, extract RNA, then reverse transcribe and pre-amplify mRNA transcripts automatically in order to detect and analyze cellular activity.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.